Top View
- Avoidance of Dopamine-Blocking Medications in Patients with Parkinson's Disease
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Swine Anesthesia and Analgesia, 2000-2010
- WO 2017/149392 Al 8 September 2017 (08.09.2017) P O P C T
- Downloaded From
- Serotonin-Based Pharmacotherapy for Acute Neuroleptic-Induced Akathisia
- Generation Antipsychotics for Children and Young Adults Comparative Effectiveness Review Number 39
- Pharmacology Premedication
- NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
- 42X60 Horizontal Poster
- FEI Prohibited Substances List the 2011 List of FEI Prohibited Substances Will Come Into Effect on 4 April 2011
- Bioactive Compound Library Plus (96-Well)
- Uniform Classification Guidelines for Foreign Substances and Recommended Penalties Model Rule
- Haematological Effect of Azaperone Sedation in Pigs
- Wo 2007/044693 A2
- United States Patent (19) 11 Patent Number: 5,955,459 Bradley Et Al
- Drugs and Medications
- Harmonized Tariff Schedule of the United States (2006) (Rev
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Training Day for Residents
- Comparative Study of the Sedative and Antinociceptive Effects of Levomepromazine, Azaperone and Midazolam in Laboratory Animals
- (12) United States Patent (10) Patent No.: US 8,232,265 B2 Rogers Et Al
- Sleep Apnea and CMV Driver Safety
- Comparison of the Sedative And/Or Antinociceptive Effects of Acepromazine, Levomepromazine and Azaperone in Horses
- Anti-Stress, Anti-Impairment and Anti-Aging Drug And
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Parkinson's Disease Quality Measurement Set Update
- Antianxiety Drugs
- Drug Repurposing Compound Library (96-Well)
- AERC Drug Rule Appendices
- Laboratory Animal Anaesthesia, Third Edition
- Promazine Group Elisa Kit Instructions Product #100719 & 100716 Forensic Use Only
- FEI EPSL Banned Substances, 25 November 2019
- (12) United States Patent (10) Patent No.: US 6,174,890 B1 Riga Et Al
- Substance Activity
- TEXAS RACING COMMISSION Classification Guidelines For
- Dopamine Receptor